Forward Pharma A/S - FWP Stock Forecast, Price & News

Forward Pharma A/S's stock was trading at $5.97 at the beginning of the year. Since then, FWP shares have decreased by 51.8% and is now trading at $2.88.
View the best growth stocks for 2022 here.

Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.06.

Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Celldex Therapeutics (CLDX), Catalyst Pharmaceuticals (CPRX), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Onconova Therapeutics (ONTX).

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

Shares of FWP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FWP stock can currently be purchased for approximately $2.88.

Forward Pharma A/S (NASDAQ:FWP) has a market capitalization of $20.42 million.

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The official website for the company is www.forward-pharma.com. The biotechnology company can be reached via phone at (453) 344-4242 or via email at investors@forward-pharma.com.